Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059703) titled 'Efficacy of brolucizumab for diabetic macular edema and identification of treatment-resistant factors' on Nov. 8.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Gunma University
Condition:
Condition - Diabetic macular edema
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the efficacy of the treat-and-extend regimen with brolucizumab in diabetic macular edema. Additionally, to analyze various laboratory data, imaging...